BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 21763117)

  • 1. Shigella are versatile mucosal pathogens that circumvent the host innate immune system.
    Ashida H; Ogawa M; Mimuro H; Kobayashi T; Sanada T; Sasakawa C
    Curr Opin Immunol; 2011 Aug; 23(4):448-55. PubMed ID: 21763117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shigella deploy multiple countermeasures against host innate immune responses.
    Ashida H; Ogawa M; Kim M; Suzuki S; Sanada T; Punginelli C; Mimuro H; Sasakawa C
    Curr Opin Microbiol; 2011 Feb; 14(1):16-23. PubMed ID: 20934372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis.
    Fernandez MI; Sansonetti PJ
    Int J Med Microbiol; 2003 Apr; 293(1):55-67. PubMed ID: 12755366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shigella infection of intestinal epithelium and circumvention of the host innate defense system.
    Ashida H; Ogawa M; Mimuro H; Sasakawa C
    Curr Top Microbiol Immunol; 2009; 337():231-55. PubMed ID: 19812985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular survival of Shigella.
    Ogawa M; Sasakawa C
    Cell Microbiol; 2006 Feb; 8(2):177-84. PubMed ID: 16441429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The versatility of Shigella effectors.
    Ogawa M; Handa Y; Ashida H; Suzuki M; Sasakawa C
    Nat Rev Microbiol; 2008 Jan; 6(1):11-6. PubMed ID: 18059288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new paradigm of bacteria-gut interplay brought through the study of Shigella.
    Sasakawa C
    Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(3):229-43. PubMed ID: 20228623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes.
    Killackey SA; Sorbara MT; Girardin SE
    Front Cell Infect Microbiol; 2016; 6():38. PubMed ID: 27066460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immune responses to intestinal bacterial pathogens.
    Bloom PD; Boedeker EC
    Semin Gastrointest Dis; 1996 Jul; 7(3):151-66. PubMed ID: 8817767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Shigella strategy for host defense and mucosal infection].
    Ogawa M; Sasakawa C
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):988-95. PubMed ID: 21089529
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenesis of Shigella: the study of bacteria-host interplay at the intestinal mucosal barriers].
    Sasakawa C
    Nihon Saikingaku Zasshi; 2012; 67(4):257-68. PubMed ID: 23269180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?
    Phalipon A; Sansonetti PJ
    Immunol Cell Biol; 2007; 85(2):119-29. PubMed ID: 17213832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Orchestra and Its Maestro: Shigella's Fine-Tuning of the Inflammasome Platforms.
    Hermansson AK; Paciello I; Bernardini ML
    Curr Top Microbiol Immunol; 2016; 397():91-115. PubMed ID: 27460806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bacterial weaponry: lessons from Shigella.
    Sansonetti PJ
    Ann N Y Acad Sci; 2006 Aug; 1072():307-12. PubMed ID: 17057210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Septins restrict inflammation and protect zebrafish larvae from Shigella infection.
    Mazon-Moya MJ; Willis AR; Torraca V; Boucontet L; Shenoy AR; Colucci-Guyon E; Mostowy S
    PLoS Pathog; 2017 Jun; 13(6):e1006467. PubMed ID: 28650995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between Shigella flexneri and the Autophagy Machinery.
    Krokowski S; Mostowy S
    Front Cell Infect Microbiol; 2016; 6():17. PubMed ID: 26904515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri.
    Sansonetti PJ; Tran Van Nhieu G; Egile C
    Clin Infect Dis; 1999 Mar; 28(3):466-75. PubMed ID: 10194063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Do the Virulence Factors of
    Mattock E; Blocker AJ
    Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050
    [No Abstract]   [Full Text] [Related]  

  • 19. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telling apart friend from foe: discriminating between commensals and pathogens at mucosal sites.
    Srinivasan N
    Innate Immun; 2010 Dec; 16(6):391-404. PubMed ID: 20083498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.